News & Videos

This holiday season is unlike any other, to finish off a year unlike any other we have known.

We’d like to take this opportunity to thank our companies, investors and co-investors for their patience and support in 2020.

Throughout this season and as we move into 2021, we wish you moments of peace amid the difficulties, and connections with your families and friends, even if they can’t be in person.

Best wishes

George, Ross, Christopher & James

– The OIC Partners

• Mind Foundry Ltd is commercialising a Collaborative AI Platform that is solving real-world problems.
• OTIF’s investment was advised by Oxford Investment Consultants LLP and was part of a £10.5m round led by Aioi Nissay Dowa Insurance Co., Ltd. (ANDI) of the MS&AD Insurance Group (TYO: 8725).
• This is the third OTIF investment in Mind Foundry Ltd to date, bringing total funds invested by OTIF in the Company to £1.2m.

Spun out of the University of Oxford in 2018, OIC portfolio company Oxford Brain Diagnostics (OBD) specialises in the measurement of neurodegeneration in Alzheimer’s disease.

Heiner is a former executive of Roche Diagnostics AG with more than 35 years of industry experience and a pioneer in the early adoption of polymerase chain reaction (PCR) technology. This appointment follows the completion of a $12m Series A round in 3Q 2020, in which OIC invested £350k.

Prof Henry Snaith FRS, Professor of Physics in the Clarendon Laboratory at the University of Oxford and co-founder and CSO of OIC portfolio company Oxford PV, has received the Becquerel Prize for his ground-breaking work on perovskite solar cells.